Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study
Martin J. van den Bent(Erasmus MC Cancer Institute), Brigitta G. Baumert(Kantonsspital Graubünden), Anja Gijtenbeek(Radboud University Nijmegen), Warren Mason(Princess Margaret Cancer Centre), Anna K. Nowak(The University of Western Australia), Jaap C. Reijneveld(Amsterdam UMC Location University of Amsterdam), Catherine McBain(Unknown), Matthew Griffin(Nottingham University Hospitals NHS Trust), Michael Weller(University Hospital of Zurich), Sanjeev Gill(The Alfred Hospital), Pim J. French(Erasmus MC Cancer Institute), S. C. Erridge(Western General Hospital), Walter Taal(Heidelberg University), Iris de Heer(Erasmus MC Cancer Institute), Sarah Nuyens(European Organisation for Research and Treatment of Cancer), Thierry Lesimple, Thierry Gorlia(European Organisation for Research and Treatment of Cancer), Peter Hau(University Hospital Regensburg), Roelien H. Enting(University of Groningen), Francesca Caparrotti(University Hospital of Geneva), Pieter Wesseling(Radboud University Nijmegen), Susan Clenton(Weston Park Cancer Centre), Robert B. Jenkins(Dartmouth–Hitchcock Medical Center), Kenneth Aldape(National Institutes of Health), Ulrich Herrlinger(University of Tübingen), Marc Sanson(Centre National de la Recherche Scientifique), Johan M. Kros(Erasmus MC), Olivier Chinot(Aix-Marseille Université), C. Mircea S. Tesileanu(Erasmus MC Cancer Institute), Leland Rogers(NRG Oncology), Helen Wheeler(The University of Sydney), Wolfgang Wick(German Cancer Research Center), Elizabeth Lim(Plymouth Hospital), Alba A. Brandes(Istituto delle Scienze Neurologiche di Bologna), F. Dhermain(Institut Gustave Roussy), Roberta Rudà, Jean Français Baurain(Cliniques Universitaires Saint-Luc), Michael A. Vogelbaum, Hendrikus J. Dubbink(Erasmus MC), Vassilis Golfinopoulos(Champalimaud Foundation), Paul M. Clément(Universitair Ziekenhuis Leuven)
Cited by 333
Related Papers
The Somatic Genomic Landscape of Glioblastoma
|Cell|2013|5.2k
Pan-cancer analysis of whole genomes
|Nature|2020|3.3k
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
|New England Journal of Medicine|2014|2.8k
Paraneoplastic anti– <i>N</i> ‐methyl‐ <scp>D</scp> ‐aspartate receptor encephalitis associated with ovarian teratoma
|Annals of Neurology|2007|2.5k
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
|New England Journal of Medicine|2016|2k